LEI110 is a potent and selective pan-inhibitor of the HRASLS thiol hydrolase family, including PLA2G16 (Ki=20 nM), HRASLS2, RARRES3, and iNAT. This small molecule is a valuable research tool for studying lipid metabolism and signaling in both cellular and animal models of metabolic disorders and cancer.